Analysis of the specificity of the SD Biosensor Standard Q Ag-Test based on Slovak mass testing data
Preprint
Abstract
From 31.10. - 1.11.2020 Slovakia has used the SD Biosensor Standard Q Ag-Test for nationwide tests for SARS-CoV-2, in which 3,625,332 persons from 79 counties were tested. Based on this data, we calculate that the specificity of the test is at least 99.6% (with a 97.5% one-sided lower confidence bound). Our analysis is based on a worst case approach in which all positives are assumed to be false positives. Therefore, the actual specificity is expected to exceed 99.6%.Keywords
All Related Versions
- Published version: PLOS ONE, 16 (7), e0255267.
This publication has 8 references indexed in Scilit:
- The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in SlovakiamedRxiv, 2020
- Rethinking Covid-19 Test Sensitivity — A Strategy for ContainmentNew England Journal of Medicine, 2020
- Comparison of seven commercial SARS-CoV-2 rapid Point-of-Care Antigen testsmedRxiv, 2020
- Urgent need of rapid tests for SARS CoV-2 antigen detection: Evaluation of the SD-Biosensor antigen test for SARS-CoV-2Journal of Clinical Virology, 2020
- Head-to-head comparison of SARS-CoV-2 antigen-detecting rapid test with self-collected anterior nasal swab versus professional-collected nasopharyngeal swabmedRxiv, 2020
- Evaluation of the accuracy, ease of use and limit of detection of novel, rapid, antigen-detecting point-of-care diagnostics for SARS-CoV-2medRxiv, 2020
- Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infectionCochrane Database of Systematic Reviews, 2020
- Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillancemedRxiv, 2020